- Capital Cube•5 days ago
Click here to see latest analysisCapitalcube gives Albany Molecular Research, Inc. a score of 28.Our analysis is based on comparing Albany Molecular Research, Inc. with the following peers – Charles River Laboratories International, Inc., Elite Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., Sanofi Sponsored ADR, Aceto Corporation, General Electric Company, Cambrex Corporation, Ligand Pharmaceuticals Incorporated and Array […] (Read more...) The post Albany Molecular Research, Inc. – Value Analysis (NASDAQ:AMRI) : July 18, 2016 appeared first on CapitalCube.
- Capital Cube•12 days agoAlbany Molecular Research, Inc. breached its 50 day moving average in a Bullish Manner : AMRI-US : July 11, 2016
Click here to see latest analysis*Disclaimer : This is as of previous day’s closing price.Technical IndicatorsBelow is a quick look at 5 technical indicators for Albany Molecular Research, Inc.. More studies are available on the Technical Chart.IndicatorSignalClosing Price above/below 50 Day Moving AverageBullishClosing Price above/below 200 Day Moving AverageBearish50 Day Moving Average above/below 200 Day […] (Read more...) The post Albany Molecular Research, Inc. breached its 50 day moving average in a Bullish Manner : AMRI-US : July 11, 2016 appeared first on CapitalCube.
Albany Molecular Research Inc.NasdaqGS
After hours: 14.330.00 (0.00%) as of 4:44 PM EDT
|Bid||14.00 x 1000|
|Ask||16.00 x 200|
|52wk Range||12.45 - 22.48|
|Day's Range||14.26 - 14.69|
|Avg Vol (3m)||286,096|
As of 4:00 PM EDT. Market closed.